Literature DB >> 31349066

Posterior reversible encephalopathy syndrome: A review with emphasis on neuroimaging characteristics.

Syuichi Tetsuka1, Tomoko Ogawa2.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiological condition that involves the acute onset of headache, confusion, optical impairments, and seizures with accompanying vasogenic edema on brain imaging. PRES is a complex disorder with many causative factors, including underlying conditions such as hypertensive encephalopathy, eclampsia, collagen disease, and severe infection. Although the exact pathophysiological mechanism is not completely understood and remains controversial, the predominant proposed mechanism is endothelial dysfunction, which is preceded by hypertension, immunosuppressive agents, or cytotoxic medication. Magnetic resonance imaging (MRI) facilitates prompt diagnosis and treatment and leads to good outcomes. Findings are characterized by the following: hyperintensity on fluid-attenuated inversion recovery images and apparent diffusion coefficient mapping, and isointensity on diffusion weighted images involving the parieto-occipital or posterior frontal cortical-subcortical regions that are recognized in >90% of patients, and reversibility of neuroimaging abnormalities, with the latter being the most important. As an algorithm to standardize the diagnosis of PRES has not yet been developed, this review presents a diagnostic algorithm based on the types of MRI findings. This algorithm may provide a better understanding of the characteristics that compose PRES and bring us one step closer to the standardization of PRES diagnosis, helping clinicians evaluate individual features while also considering competing differential diagnoses.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diagnosis; MRI; Neuroimaging; PRES; Pathophysiology

Year:  2019        PMID: 31349066     DOI: 10.1016/j.jns.2019.07.018

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  18 in total

1.  Simultaneous acute Marchiafava-Bignami disease and posterior reversible encephalopathy syndrome: a case almost misdiagnosed.

Authors:  Liming Yang; Jing Liu; Yi Yin; Hui Yu
Journal:  Quant Imaging Med Surg       Date:  2020-06

2.  Pregabalin Toxicity-Induced Posterior Reversible Encephalopathy Syndrome.

Authors:  Feng Hsiao; Abraham Ma; Purushothaman Muthukanagaraj
Journal:  Cureus       Date:  2022-06-04

3.  Posterior reversible encephalopathy syndrome mimicking subacute ischemic stroke: a case report.

Authors:  Soichiro Yamaguchi; Hideki Endo; Yuma Hiratsuka; Hirohiko Nakamura
Journal:  Radiol Case Rep       Date:  2022-06-21

4.  Posterior Reversible Encephalopathy Syndrome Following Chemotherapy and Immune Checkpoint Inhibitor Combination in a Patient with Small-Cell Lung Cancer.

Authors:  Cécile Evin; Nathalie Lassau; Corinne Balleyguier; Tarek Assi; Samy Ammari
Journal:  Diagnostics (Basel)       Date:  2022-06-02

5.  Case Report: Subacute Sclerosing Panencephalitis in Pregnancy Mimicking Posterior Reversible Encephalopathy Syndrome.

Authors:  Praveen Kumar Sharma; Ravindra Kumar Garg; Shinu Singla
Journal:  Am J Trop Med Hyg       Date:  2020-03       Impact factor: 2.345

6.  Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size.

Authors:  Marady Hun; Min Xie; Zhou She; Amin S Abdirahman; Cuifang Li; Feifeng Wu; Senlin Luo; Phanna Han; Rithea Phorn; Pan Wu; Haiyan Luo; Keke Chen; Jidong Tian; Wuqing Wan; Chuan Wen
Journal:  Front Pediatr       Date:  2021-07-01       Impact factor: 3.418

7.  Clinical and MRI Features of Posterior Reversible Encephalopathy Syndrome With Atypical Regions: A Descriptive Study With a Large Sample Size.

Authors:  Kunhua Li; Yang Yang; Dajing Guo; Dong Sun; Chuanming Li
Journal:  Front Neurol       Date:  2020-03-24       Impact factor: 4.003

8.  [Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report].

Authors:  L Ordoñez-Boschetti; C M Torres-Romero; M J Ortiz de Leo
Journal:  Neurologia (Engl Ed)       Date:  2020-08-10

9.  Cognitive Sequelae of Central-Variant Posterior Reversible Encephalopathy Syndrome (PRES).

Authors:  Joseph Seemiller; Muhammad Taimur Malik
Journal:  Case Rep Neurol Med       Date:  2021-02-05

10.  Seizures after percutaneous endoscopic lumbar discectomy: A case report.

Authors:  Junbei Wu; Yin Fang; Wenjie Jin
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.